RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 163 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $325,000 | 0.0% | 92,931 | 0.0% | 0.02% | -52.2% |
| Q4 2020 | $325,000 | +146.2% | 92,931 | +68.9% | 0.05% | +91.7% |
| Q3 2020 | $132,000 | +200.0% | 55,024 | +128.9% | 0.02% | +140.0% |
| Q2 2020 | $44,000 | -59.3% | 24,037 | -41.8% | 0.01% | -60.0% |
| Q2 2019 | $108,000 | – | 41,314 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 4,500,000 | $11,925,000 | 4.90% |
| HealthInvest Partners AB | 1,090,000 | $2,889,000 | 4.07% |
| GREAT POINT PARTNERS LLC | 5,000,000 | $13,250,000 | 2.94% |
| CM Management, LLC | 775,000 | $2,054,000 | 1.55% |
| SECTOR GAMMA AS | 1,469,604 | $3,894,000 | 0.92% |
| Sio Capital Management, LLC | 913,621 | $2,421,000 | 0.73% |
| Telemetry Investments, L.L.C. | 190,000 | $504,000 | 0.65% |
| DAFNA Capital Management LLC | 879,000 | $2,329,000 | 0.59% |
| Rock Springs Capital Management LP | 4,860,200 | $12,880,000 | 0.30% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $4,074,000 | 0.27% |